InvestorsHub Logo
Followers 63
Posts 8502
Boards Moderated 0
Alias Born 01/10/2014

Re: None

Tuesday, 12/31/2019 10:33:16 AM

Tuesday, December 31, 2019 10:33:16 AM

Post# of 1874
Very good article for ONCY.

Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus: a first-in-class intravenously delivered immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. The compound induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses to treat a variety of cancers and has been demonstrated to be able to escape neutralizing antibodies found in patients.


https://seekingalpha.com/pr/17726370-oncolytics-biotech-r-announces-abstract-outlining-potential-new-biomarker-to-be-presented

Statements made are only my opinion. Do your own DD in order to make your Investment decisions.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCY News